LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Novartis Gene Therapies and Millions of Other Companies

Sign up for full access to Novartis Gene Therapies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Gene Therapy Advancements Novartis Gene Therapies has launched innovative gene therapy platforms like T-Charge CAR-T, showcasing a commitment to cutting-edge treatments for rare genetic diseases. Sales opportunities exist in promoting these advancements to healthcare providers and institutions looking for advanced treatment options.

Recent Investments Recent investments from firms like Toussaintfinancial and Granite Bay Wealth Management indicate strong investor confidence in Novartis Gene Therapies. Sales representatives can leverage this financial backing as a testament to the company's growth potential and stability when engaging with potential partners or clients.

Strategic Partnerships Collaborations with entities like Clarius Mobile Health Corp present sales opportunities for Novartis Gene Therapies to broaden its reach and offerings. Sales development professionals can highlight these partnerships to showcase the company's commitment to expanding healthcare solutions and accessing new markets.

Market Expansion Through Acquisitions Acquiring assets like Leqvio demonstrates Novartis Gene Therapies' strategic approach to expanding its product portfolio. Sales teams can leverage these acquisitions as a competitive advantage, positioning the company as a comprehensive provider of genetic disease treatments to potential clients and partners.

Financial Strength and Growth With a revenue range of $100M - 1B and funding of $2.4B, Novartis Gene Therapies is financially robust and poised for growth. Sales professionals can use this information to instill confidence in potential clients regarding the company's stability and ability to deliver cutting-edge gene therapies effectively.

Similar companies to Novartis Gene Therapies

✕

Access Insights for Novartis Gene Therapies and Millions of Other Companies

Sign up for full access to Novartis Gene Therapies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Novartis Gene Therapies Tech Stack

Novartis Gene Therapies uses 8 technology products and services including Medallia, Azure Analysis Services, Five9, and more. Explore Novartis Gene Therapies's tech stack below.

  • Medallia
    Analytics
  • Azure Analysis Services
    Analytics
  • Five9
    Contact Center Solutions
  • Drupal 7
    Content Management System
  • SAP Information Steward
    Data Integration
  • Cerner
    Electronic Health Records
  • Buildout
    Real Estate Marketing
  • Apache
    Web Servers

Media & News

Novartis Gene Therapies's Email Address Formats

Novartis Gene Therapies uses at least 1 format(s):
Novartis Gene Therapies Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
90%
F.Last@novartis.comJ.Doe@novartis.com
6%
FLast@novartis.comJDoe@novartis.com
3%
First.L@novartis.comJohn.D@novartis.com
1%

Frequently Asked Questions

Where is Novartis Gene Therapies's headquarters located?

Minus sign iconPlus sign iconNovartis Gene Therapies's main headquarters is located at 2275 Half Day Road Suite 200 Bannockburn, llinois 60015 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Novartis Gene Therapies's official website and social media links?

Minus sign iconPlus sign iconNovartis Gene Therapies's official website is novartis.com and has social profiles on LinkedIn.

How much revenue does Novartis Gene Therapies generate?

Minus sign iconPlus sign icon As of October 2024, Novartis Gene Therapies's annual revenue reached $750M.

What is Novartis Gene Therapies's SIC code NAICS code?

Minus sign iconPlus sign iconNovartis Gene Therapies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Novartis Gene Therapies have currently?

Minus sign iconPlus sign iconAs of October 2024, Novartis Gene Therapies has approximately 1K employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Access Commercial Officer (formerly Avexis): T. S.Vice President Marketing: J. P.Vice President Global Commercial Analytics & Sales Operations: J. D.. Explore Novartis Gene Therapies's employee directory with LeadIQ.

What industry does Novartis Gene Therapies belong to?

Minus sign iconPlus sign iconNovartis Gene Therapies operates in the Biotechnology Research industry.

What technology does Novartis Gene Therapies use?

Minus sign iconPlus sign iconNovartis Gene Therapies's tech stack includes MedalliaAzure Analysis ServicesFive9Drupal 7SAP Information StewardCernerBuildoutApache.

What is Novartis Gene Therapies's email format?

Minus sign iconPlus sign iconNovartis Gene Therapies's email format typically follows the pattern of . Find more Novartis Gene Therapies email formats with LeadIQ.

How much funding has Novartis Gene Therapies raised to date?

Minus sign iconPlus sign icon As of October 2024, Novartis Gene Therapies has raised $2.4B in funding. The last funding round occurred on Sep 16, 2020 for $2.1B.
Novartis Gene Therapies

Novartis Gene Therapies

Biotechnology Researchllinois , United States1001-5000 Employees

Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA).

Read Our Community Guidelines: https://bit.ly/39UB7ka

How to reach us:
Novartis Gene Therapies
2275 Half Day Road, Suite 200
Bannockburn, IL 60015
Email: gtx.communications@novartis.com 
Office Phone: 847.572.8280
Toll-free Phone: 844.428.3947

✕

Access Insights for Novartis Gene Therapies and Millions of Other Companies

Sign up for full access to Novartis Gene Therapies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
2275 Half Day Road Suite 200 Bannockburn, llinois 60015 US
Website
novartis.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $2.4B

    Novartis Gene Therapies has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $100M$1B

    Novartis Gene Therapies's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $2.4B

    Novartis Gene Therapies has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $100M$1B

    Novartis Gene Therapies's revenue is in the range of $100M$1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Novartis Gene Therapies and Millions of Other Companies

Sign up for full access to Novartis Gene Therapies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.